FDA Drug/Biologics Approval BLA 125057 S-393, ADALIMUMAB

FDA Drug/Biologics Approval BLA 125057 S-393, ADALIMUMAB

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125057 S-393
Company: ABBVIE INC
Drug Name: HUMIRA
Active Ingredients: ADALIMUMAB
Strength: 40MG/0.8ML
Dosage Form/Route: VIAL
Action Date: 12/31/2002
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details